TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Targacept , Inc. (NASDAQ:TRGT) Investor Investigation Concerning Potential Securities Laws Violations

  • If you purchased shares of Targacept , Inc. (NASDAQ:TRGT), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Targacept , Inc.
Security
NASDAQ: TRGT

Summary

December 17, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Targacept , Inc. (NASDAQ:TRGT) shares over potential securities laws violations by Targacept and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Targacept , Inc. (NASDAQ:TRGT) concerning whether a series of statements by Targacept ,. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Targacept , Inc. reported that its annual Total Revenue declined from $97.64 million in 2011 to $57.86 million in 2012 while its Net Loss decreased from $8.53 million in 2011 to $7.00 million in 2012.

Shares of Targacept , Inc. grew from under $ in late 2012 to as high as $6.08 per share on December 16, 2013.

Then on December 16, 2013, Targacept , Inc. announced negative Top-Line Results from Phase 2b Clinical Trial of TC-5619 in Schizophrenia.

Shares of Targacept , Inc. dropped on December 17, 2013, to as low as $3.91 per share.

Start Monitoring Your Investments